toluene has been researched along with oxidopamine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agnati, LF; Andbjer, B; Cintra, A; Finnman, UB; Fuxe, K; Hagman, M; Höglund, G | 1 |
Agnati, LF; Aguirre, JA; Andbjer, B; Cintra, A; Finnman, UB; Fuxe, K; Hagman, M; Höglund, C; Möller, A | 1 |
Ali, SF; French, ED; Riegel, AC | 1 |
Bennett, MC; Chase, TN; Han, R; Li, YL; Liang, ZQ; Qin, ZH; Wang, XX; Wang, Y; Zhao, XL | 1 |
4 other study(ies) available for toluene and oxidopamine
Article | Year |
---|---|
Subacute toluene exposure increases DA dysfunction in the 6-OH dopamine lesioned nigrostriatal dopaminergic system of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Drug Administration Schedule; Drug Synergism; Male; Neurotoxins; Norepinephrine; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra; Toluene | 1996 |
Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Behavior, Animal; Denervation; Dopamine; Injections, Intraventricular; Male; Motor Activity; Neostriatum; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Substantia Nigra; Toluene; Tyrosine 3-Monooxygenase | 1999 |
Toluene-induced locomotor activity is blocked by 6-hydroxydopamine lesions of the nucleus accumbens and the mGluR2/3 agonist LY379268.
Topics: Amino Acids; Animals; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Male; Motor Activity; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Toluene | 2003 |
NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.
Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; Benzothiazoles; DNA Fragmentation; Dopamine; Male; Nerve Degeneration; Neurons; Neurotoxins; NF-kappa B; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Peptides; Rats; Rats, Sprague-Dawley; Signal Transduction; Substantia Nigra; Sympatholytics; Toluene; Tumor Suppressor Protein p53; Tyrosine 3-Monooxygenase | 2007 |